blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3167076

EP3167076 - METHODS AND PRODUCTS FOR QUANTIFYING RNA TRANSCRIPT VARIANTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.09.2022
Database last updated on 08.01.2025
FormerThe patent has been granted
Status updated on  15.10.2021
FormerGrant of patent is intended
Status updated on  10.06.2021
FormerExamination is in progress
Status updated on  12.01.2018
FormerRequest for examination was made
Status updated on  18.04.2017
FormerThe international publication has been made
Status updated on  08.02.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Lexogen GmbH
Campus-Vienna-Biocenter 5
Helmut Qualtinger-Gasse 6
1030 Vienna / AT
[2017/20]
Inventor(s)01 / PAUL, Lukas
Stipcakgasse 9-17
Haus 16
A-1230 Vienna / AT
02 / KUBALA, Petra
Simonygasse 2B
12/3
A-1180 Vienna / AT
03 / REDA, Torsten
Nachtigallenweg 24
A-1140 Vienna / AT
 [2017/20]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2021/46]SONN Patentanwälte OG
Riemergasse 14
1010 Wien / AT
Former [2017/20]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date15736490.209.07.2015
[2017/20]
WO2015EP65756
Priority number, dateEP2014017641709.07.2014         Original published format: EP 14176417
[2017/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016005524
Date:14.01.2016
Language:EN
[2016/02]
Type: A1 Application with search report 
No.:EP3167076
Date:17.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 14.01.2016 takes the place of the publication of the European patent application.
[2017/20]
Type: B1 Patent specification 
No.:EP3167076
Date:17.11.2021
Language:EN
[2021/46]
Search report(s)International search report - published on:EP14.01.2016
ClassificationIPC:C12Q1/68
[2017/20]
CPC:
C12Q1/6806 (EP,KR,US); C12Q1/6844 (EP,KR,US); C12Q1/6869 (EP,CN,KR,US);
C12Q1/682 (US); C12Q1/6846 (US); C12Q1/686 (US);
C12Q2545/113 (KR); C12Q2600/166 (EP,KR,US) (-)
C-Set:
C12Q1/6806, C12Q2545/113 (EP,US);
C12Q1/6869, C12Q2545/113 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/20]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERFAHREN UND PRODUKTE ZUR QUANTIFIZIERUNG VON RNA-TRANSKRIPT-VARIANTEN[2017/20]
English:METHODS AND PRODUCTS FOR QUANTIFYING RNA TRANSCRIPT VARIANTS[2017/20]
French:PROCÉDÉS ET PRODUITS PERMETTANT DE QUANTIFIER DES VARIANTS DE TRANSCRIPTION D'ARN[2021/22]
Former [2017/20]PROCÉDÉS ET PRODUITS POUR LA QUANTIFICATION DE VARIANTS DE PRODUITS DE TRANSCRIPTION D'ARN
Entry into regional phase08.02.2017National basic fee paid 
08.02.2017Designation fee(s) paid 
08.02.2017Examination fee paid 
Examination procedure08.02.2017Amendment by applicant (claims and/or description)
08.02.2017Examination requested  [2017/20]
08.02.2017Date on which the examining division has become responsible
11.01.2018Despatch of a communication from the examining division (Time limit: M06)
11.07.2018Reply to a communication from the examining division
31.07.2018Despatch of a communication from the examining division (Time limit: M06)
04.02.2019Reply to a communication from the examining division
03.06.2019Despatch of a communication from the examining division (Time limit: M06)
13.12.2019Reply to a communication from the examining division
09.04.2020Despatch of a communication from the examining division (Time limit: M06)
12.10.2020Reply to a communication from the examining division
11.02.2021Despatch of a communication from the examining division (Time limit: M04)
08.03.2021Reply to a communication from the examining division
11.06.2021Communication of intention to grant the patent
07.10.2021Fee for grant paid
07.10.2021Fee for publishing/printing paid
07.10.2021Receipt of the translation of the claim(s)
Opposition(s)18.08.2022No opposition filed within time limit [2022/43]
Fees paidRenewal fee
10.07.2017Renewal fee patent year 03
09.07.2018Renewal fee patent year 04
08.07.2019Renewal fee patent year 05
09.07.2020Renewal fee patent year 06
09.07.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.07.2015
AL17.11.2021
CY17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
MK17.11.2021
MT17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
LU09.07.2022
[2024/41]
Former [2024/22]HU09.07.2015
AL17.11.2021
CY17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
MK17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
LU09.07.2022
Former [2024/20]HU09.07.2015
AL17.11.2021
CY17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
LU09.07.2022
Former [2024/18]HU09.07.2015
AL17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
LU09.07.2022
Former [2023/21]AL17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
LU09.07.2022
Former [2023/11]AL17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
MC17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2023/01]AL17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SI17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/49]AL17.11.2021
CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/35]CZ17.11.2021
EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SK17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/34]EE17.11.2021
ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RO17.11.2021
RS17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/33]ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RS17.11.2021
SM17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/24]ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RS17.11.2021
BG17.02.2022
GR18.02.2022
PT17.03.2022
Former [2022/23]ES17.11.2021
HR17.11.2021
LV17.11.2021
PL17.11.2021
RS17.11.2021
BG17.02.2022
PT17.03.2022
Former [2022/21]RS17.11.2021
BG17.02.2022
Former [2022/19]BG17.02.2022
Cited inInternational search[A]US2004009512  (ARES MANUEL [US], et al);
 [A]EP2333104  (LEXOGEN GMBH [AT]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.